TLX · Telix Pharmaceuticals Ltd · Documents
Market Cap
$3.20B
Shares
338.78M
Volume · Oct 22
534.49K
Avg daily vol (3M)
291.28K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 6-K | — | 2025-04-04 | 2025-04-03 | |
| 6-K | — | 2025-03-21 | 2025-03-20 | |
| 6-K | — | 2025-03-18 | 2025-03-17 | |
| 6-K | — | 2025-03-12 | 2025-03-11 | |
| 6-K | — | 2025-02-27 | 2025-02-25 | |
| 6-K | — | 2025-02-26 | 2025-02-25 | |
| 6-K | — | 2025-02-25 | — | |
| 20-F | — | 2025-02-24 | 2024-12-31 | |
| 6-K | — | 2025-02-24 | — | |
| 6-K | — | 2025-02-21 | 2025-02-20 | |
| 6-K | — | 2025-02-13 | 2025-02-12 | |
| 6-K | — | 2025-01-31 | 2025-01-30 | |
| 6-K | — | 2025-01-27 | — | |
| 6-K | — | 2025-01-17 | 2025-01-16 | |
| 6-K | — | 2025-01-13 | — | |
| 6-K | — | 2025-01-13 | 2025-01-12 | |
| 6-K | — | 2024-12-30 | 2024-12-29 | |
| 6-K | — | 2024-11-19 | — | |
| 6-K | — | 2024-11-14 | 2024-11-12 | |
| F-1/A | — | 2024-06-05 | — | |
| F-1 | — | 2024-05-17 | — |
Showing 51–71 of 71 filings
Key facts
CIK
2007191
CUSIP
87961M105
13F (30d)
10 filings
10 filers
Visit website
Investor relations